drugset / Trial / NCT01058018
Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to investigate dose range, safety and efficacy of RVX000222 in subjects with stable coronary artery disease.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-06
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apabetalone | Small molecule | 50 mg | Oral |
| Subject | Apabetalone | Small molecule | 100 mg | Oral |
| Subject | Apabetalone | Small molecule | 150 mg | Oral |